Owlet's Guidance Reset Creates Expectation Arbitrage Trade as 2026 Outlook Falters

Owlet delivered a clear beat on its fourth-quarter numbers, but the market's reaction tells the real story. The company posted an adjusted net loss per share of $0.03, crushing the consensus estimate of a $0.13 loss. That's a 76% surprise, marking the fourth consecutive quarter the stock has topped expectations. Revenue also came in strong at $26.6 million, beating estimates by 4.6% and growing 29.6% year-over-year. For the full year, Owlet hit a record $105.7 million in revenue.

So why did the stock slump 26% after hours? The answer is a guidance reset that created a larger expectation gap for the near term. While the quarterly print was impressive, the forward view was disappointing. Management's forecast for the first quarter of 2026 called for revenue between $20 million and $21 million. That range was significantly lower than the Wall Street consensus of $26.2 million. In other words, the market had priced in a strong start to the year based on the robust Q4 growth. The guidance reset suggests a slowdown, and that's what the stock punished.

The setup is classic expectation arbitrage. The whisper number for Q1 was high, fueled by the momentum of a record-breaking quarter. Owlet's actual guidance was a reset lower, revealing a reality that was less optimistic than the market had priced in. The beat on the quarterly numbers was already in the stock price; the disappointment was in the forward path.

The Guidance Reset: Where Expectations Collided

The market's harsh reaction wasn't about the past quarter's beat; it was a reset of the future view. Management's forward commentary created a clear expectation gap that overshadowed the strong Q4 print.

The near-term numbers were a disappointment. For the first quarter of 2026, Owlet guided revenue to a range of $20 million to $21 million. That forecast was significantly lower than the Wall Street consensus of $26.2 million. In other words, the market had priced in a strong start to the year based on the momentum of a record-breaking quarter. The guidance reset suggests a slowdown, and that's what the stock punished.

Zooming out, the full-year outlook also implied a deceleration. Management's forecast for 2026 revenue of $126 million to $130 million represents growth of 19% to 23% over 2025. That's a notable step down from the 35.4% increase the company achieved last year. The narrative shifted from pure, breakneck growth to one focused on sustainability and margin expansion.

This reset was compounded by a tangible headwind. The company's gross margin decreased by 596 basis points year-over-year in Q4, with tariffs cited as the primary driver. Management noted tariffs materially pressured margins, with an impact of about 510 basis points in the quarter alone. This creates a dual challenge: guiding for lower top-line growth while facing ongoing pressure on profitability. The expectation gap wasn't just about revenue; it was about the quality and durability of that growth.

Financial Health and the Path to Profitability

The core business drivers reveal a company making tangible progress on the path to profitability, even as it grapples with a significant headwind. The most critical metric for that journey is gross margin, which contracted sharply in the quarter. Owlet's gross margin fell 596 basis points year-over-year to 47.6% in Q4, with tariffs cited as the primary cause. This is a key headwind for profitability, as it directly pressures the company's ability to convert sales into profit. The full-year impact was also material, with tariffs reducing gross margin by 270 basis points for the year.

Yet, the trajectory toward operational profitability is clear. For the full year, Owlet achieved a major milestone: adjusted EBITDA turned positive at $2 million, a significant improvement from a $1.8 million loss in 2024. This $3.8 million swing to profitability demonstrates that the company is gaining operating leverage as it scales. Management noted that Q4 operating expenses were actually down from the prior year, highlighting disciplined cost control amid growth.

The engine for this improvement is the subscription business. Owlet highlighted strong momentum in its Owlet360 platform, with the service surpassing 110,000 paying subscribers. This is a key metric for lifetime value, as recurring subscription revenue provides a more predictable and higher-margin income stream than hardware sales alone. The company is betting on this model to drive future profitability, with plans for new camera-specific features and an AI roadmap to extend customer lifetime value.

The bottom line is a story of progress meeting pressure. The company has turned the corner on EBITDA, but the tariff-driven margin contraction shows that achieving sustainable, high-margin profitability will require navigating external costs. The path forward hinges on the scalability and margin profile of the subscription base to offset these headwinds.

Catalysts and Risks: What to Watch Next

The current low valuation is a bet that Owlet's guidance reset is temporary and that hidden catalysts will drive a re-rating. The near-term path hinges on three key developments.

First, investors must monitor the company's execution against its own lowered Q1 guidance. The forecast of $20 million to $21 million in revenue is a clear benchmark. If Owlet can deliver within or above that range, it would validate the guidance as a conservative, achievable target rather than a sign of deeper trouble. More importantly, a strong start could set the stage for a "beat and raise" in the second quarter, which would be the clearest signal that the market's initial pessimism was overdone. The stock's 26% after-hours drop shows how sensitive it is to any deviation from the reset trajectory.

Second, watch for tangible progress on the healthcare expansion, which represents a major potential growth catalyst. Management has highlighted the planned launch of an Owlet-branded pediatric telehealth service and the potential for expanded Medicaid and commercial reimbursement coverage. Success here could unlock a new, higher-margin revenue stream and significantly extend customer lifetime value. The company's focus on this channel in 2026 is a clear signal of its strategic importance. Any updates on pilot programs, partnerships, or reimbursement approvals will be critical milestones to watch.

The primary risk, however, remains sustained tariff pressure and its impact on margins. The company's own numbers show tariffs materially pressured gross margins, with a 510 basis point hit in Q4 alone. While management guided for a gross margin range of 49% to 52% for the full year, that still implies a significant compression from the record 50.6% achieved in 2025. If tariff costs remain elevated or new duties are imposed, they could delay the path to consistent profitability, even if revenue growth holds. This headwind is the counterweight to the bullish telehealth narrative.

In short, the setup is a classic expectation arbitrage play. The market has priced in a slowdown and margin pressure. The stock's fate now depends on whether Owlet can prove that its healthcare catalysts are real and that its operational discipline can offset the tariff overhang. The coming quarters will test if the current low valuation is a bargain or a warning.